Skip to Content Skip to Content

Internal Medicine

Intervention in Navajo Nation boosts uptake for heart failure drugs by 53%
A sign that reads Welcome to the Navajo Nation.

Image: Courtesy of Penn LDI

Intervention in Navajo Nation boosts uptake for heart failure drugs by 53%

LDI senior fellow Lauren Eberly details her latest study on the Navajo Nation reservation in New Mexico, highlighting the increased uptake of guideline-directed heart failure therapy drugs.

Hoag Levins

The Penn doctor leading the way in heart health with TAVR innovation
Howard Hermann.

Howard Herrmann is the John Winthrop Bryfogle Professor of Cardiovascular Diseases in the Perelman School of Medicine.

(Image: Courtesy of Penn Medicine News)

The Penn doctor leading the way in heart health with TAVR innovation

Howard Herrmann, the John Winthrop Bryfogle Professor of Cardiovascular Diseases in the Perelman School of Medicine and Health System director for Interventional Cardiology, is a lead researcher in the TAVR field.

From Penn Medicine News

Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions

Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions

Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.

A successful new experiment opens potential for future bridge-to-transplant approach
Human body with a rendering of liver in the foreground.

Image: iStock/Mohammed Haneefa Nizamudeen

A successful new experiment opens potential for future bridge-to-transplant approach

A team at Penn Medicine has achieved the first successful external liver perfusion using a porcine liver, raising hopes for a possible effective option to “bridge” critically ill patients to liver transplant.

From Penn Medicine News